Lv1
90 积分 2025-07-15 加入
Recent advancements in fusion protein technologies in oncotherapy: A review
2天前
已完结
Stability of l-asparaginase: an enzyme used in leukemia treatment
6天前
已关闭
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
15天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
15天前
已完结
Advances in systemic therapies for triple negative breast cancer
15天前
已完结
Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy
16天前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
17天前
已完结
Engineering multi-specific nano-antibodies for cancer immunotherapy
18天前
已完结
Uveal melanoma
1个月前
已完结
Tebentafusp for uveal melanoma
1个月前
已完结
皖公网安备34019202002308
